Virbac SACA

Virbac : Declaration of the number of shares and voting rights 12/2025

09 Jan 2026 12:05:59 By Nasdaq GlobeNewswire

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

16 Dec 2025 03:53:22 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 11/2025

08 Dec 2025 04:13:13 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 10/2025

07 Nov 2025 09:39:51 By Nasdaq GlobeNewswire

VIRBAC Announces Third Quarter 2025 Sales

16 Oct 2025 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 09/2025

03 Oct 2025 10:55:55 By Nasdaq GlobeNewswire

Virbac: 2025 Half-year results

12 Sep 2025 11:45:00 By Nasdaq GlobeNewswire

Virbac : Half-yearly financial report 2025

12 Sep 2025 11:30:00 By Nasdaq GlobeNewswire

Virbac : Public release of the Half-Year Financial Report at 30 June 2025.

12 Sep 2025 11:30:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 08/2025

05 Sep 2025 08:45:19 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 07/2025

05 Sep 2025 08:40:35 By Nasdaq GlobeNewswire

Virbac:: Paul Martingell's compensation terms

18 Aug 2025 03:30:00 By Nasdaq GlobeNewswire

Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation

16 Jul 2025 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 06/2025

04 Jul 2025 06:04:16 By Nasdaq GlobeNewswire

VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025

19 Jun 2025 02:30:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of share and voting rights 05/2025

10 Jun 2025 03:59:29 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 04/2025

07 May 2025 10:27:25 By Nasdaq GlobeNewswire

Virbac : Public release of Virbac Annual Report at 31 December 2024

28 Apr 2025 13:00:00 By Nasdaq GlobeNewswire

Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope

15 Apr 2025 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 03/2025

09 Apr 2025 11:30:02 By Nasdaq GlobeNewswire